Workflow
艾力斯: 上海艾力斯医药科技股份有限公司2024年年度权益分派实施公告

Core Viewpoint - Shanghai Ailis Pharmaceutical Technology Co., Ltd. has announced a cash dividend distribution of RMB 0.40 per share (before tax), totaling RMB 180 million (before tax) for its shareholders, following the approval at the annual general meeting held on May 14, 2025 [1][5]. Dividend Distribution Plan - The dividend distribution is based on a total share capital of 450 million shares, with a cash dividend of RMB 0.40 per share, amounting to a total cash distribution of RMB 180 million (before tax) [1]. - The cash dividend will be distributed to all shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [1]. Relevant Dates - The key dates for the dividend distribution are as follows: - Record date - Ex-dividend date - Cash dividend payment date [1]. Taxation on Dividends - For individual shareholders holding unrestricted circulating shares: - Those holding shares for over 1 year will not be subject to personal income tax on dividend income, receiving a net cash dividend of RMB 0.40 per share [2]. - For shares held for 1 year or less, the company will not withhold personal income tax at the time of distribution; tax will be calculated upon the transfer of shares [2]. - The actual tax burden for shareholders varies based on the holding period: - Less than or equal to 1 month: 20% tax rate, effective cash dividend of RMB 0.32 per share - More than 1 month to 1 year: 10% tax rate, effective cash dividend of RMB 0.36 per share - Over 1 year: no tax [3][4]. Distribution to Foreign Investors - Qualified Foreign Institutional Investors (QFII) will have a withholding tax of 10%, resulting in an effective cash dividend of RMB 0.36 per share [4]. - For Hong Kong market investors, the same 10% withholding tax applies, with dividends distributed in RMB [4]. Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the Securities Affairs Department at 021-80423292 [4].